Baxter Nicholas W 4
4 · Lexaria Bioscience Corp. · Filed Apr 8, 2019
Insider Transaction Report
Form 4
Baxter Nicholas W
Director
Transactions
- Other
Stock Options
2019-04-05$1.53/sh−50,000$76,500→ 10,000 totalExercise: $1.53From: 2018-05-31Exp: 2023-05-31→ Common Shares (50,000 underlying)
Holdings
- 10,000
Stock Options
Exercise: $0.10From: 2014-12-23Exp: 2019-12-23→ Common Shares (10,000 underlying) - 220,000
common shares
- 60,000
Stock Options
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Cancellation of Options